NYSE Arca · APUS
Apimeds Pharmaceuticals US, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for APUS: Nov 11, 2026
Apimeds Pharmaceuticals US, Inc. Common Stock is estimated to report earnings on 11/11/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-1.4.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Quiver Quantitative- RTTNews · Sep 24, 3:06 PM EDTBiotech Stocks On The Move – APUS, PFSA, GCTK, ARCT(RTTNews) – The following biotech stocks were in focus on September 24, 2026, following notable stock moves and company-specific developments involving clinical programs, regulatory progress, financing and technology platforms.
- RTTNews · Sep 24, 1:49 PM EDTAPUS Stock Surges Over 130%; Apitox Phase 3 Path And Pipeline In Focus(RTTNews) – Apimeds Pharmaceuticals US (APUS), a clinical-stage biopharmaceutical company developing Apitox, an intradermally administered bee venom-based therapy, is trading sharply higher, with shares surging more than 130%, as investors focus on the company's clinical pipeline
- RTTNews · May 6, 10:49 AM EDTApimed Clears Path For Merger Completion And $100 Million PIPE Financing; Stock Down(RTTNews) – Apimeds Pharmaceuticals US, Inc. (APUS) yesterday said it has reached a comprehensive settlement with Inscobee, removing all outstanding disputes tied to its December 2025 merger with MindWave Innovations and allowing the long-delayed transaction and $100 million PIPE
- Quiver Quantitative · May 12, 5:20 PM EDTApimeds Pharmaceuticals US, Inc. Completes Initial Public Offering, Raising $13.5 Million for Clinical DevelopmentApimeds Pharmaceuticals closed its IPO, raising $13.5 million to fund clinical trials and general operational costs.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Apimeds Pharmaceuticals US, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.